Ipca Laboratories
Logotype for Ipca Laboratories Limited

Ipca Laboratories (IPCALAB) investor relations material

Ipca Laboratories Q3 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Ipca Laboratories Limited
Q3 25/26 earnings summary16 Feb, 2026

Executive summary

  • Domestic business grew 12% in Q3 FY26, outpacing the Indian Pharmaceutical Market's 8.9% growth year-over-year.

  • Export formulation business grew 17% in Q3 and 6% for the nine-month period; API business was flat in Q3 but up 14% for nine months.

  • Standalone net total income for Q3 FY26 rose 11% year-over-year to Rs. 1,863.00 crores; consolidated net total income increased 7% to Rs. 2,412.69 crores.

  • Standalone net profit for Q3 FY26 was Rs. 303.45 crores, up 13%; consolidated net profit was Rs. 326.27 crores, up 31%.

  • Consolidated Q3 revenue was INR 2,245 crore, up 6.5% year-over-year; nine-month consolidated revenue grew 8.44% to INR 7,258 crore.

Financial highlights

  • Standalone EBITDA margin improved to 26.09% in Q3 FY26 from 24.25% in Q3 FY25; consolidated EBITDA margin for Q3 FY26 was 22.15%, up from 19.87%.

  • Standalone EPS for Q3 FY26 was Rs. 11.96 (up 13%); consolidated EPS was Rs. 12.86 (up 31%).

  • For nine months FY26, standalone EBITDA margin was 25.15% (vs. 23.14%); consolidated EBITDA margin was 20.79% (vs. 19.18%).

  • Standalone net profit for nine months FY26 was Rs. 870.23 crores (up 22%); consolidated net profit was Rs. 842.05 crores (up 26%).

  • Material cost to sales ratio improved by 3.36 percentage points for nine months, driven by product mix and higher-margin business growth.

Outlook and guidance

  • Expect overall company growth of 10%-11% annually, with promotional branded and generic businesses each targeting 10%-12% growth.

  • EBITDA margin (ex-Unichem) expected to improve by 1.5% per year if top-line growth sustains at 10%-12%.

  • Unichem's top-line expected to grow 8%-10% annually, with EBITDA margin targeted at 15% in 2-3 years, improving to 20% as filings and registrations mature.

  • Management highlighted continued growth in both domestic and export markets, with strong performance in branded and generics segments.

Unichem US market share recovery strategy
Gross margin sustainability and drivers
GLP-1 strategy for domestic market
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Ipca Laboratories earnings date

Logotype for Ipca Laboratories Limited
Q4 25/2629 May, 2026
Ipca Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Ipca Laboratories earnings date

Logotype for Ipca Laboratories Limited
Q4 25/2629 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Ipca Laboratories Limited is an India-based pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients and finished dosage forms. The company’s products cover therapeutic segments such as pain management, cardiovascular, anti-malarial, anti-infective, and dermatology. Ipca serves domestic and international markets, supplying to both branded and generic sectors, and also operates in the institutional supply segment. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage